Greg Nowakowski, MD
Dr. Nowakowski is Professor of Medicine and Oncology in the Lymphoma Program at Mayo Clinic Rochester.
Articles by Greg Nowakowski, MD
The panel discussed novel targeted combinations in CNS lymphoma, such as BTK inhibitors in combination with IRAK inhibitors.
The panel, moderated by Grzegorz Nowakowski, MD, discussed how to manage methotrexate toxicity in CNS lymphoma.
The panel, moderated by Grzegorz Nowakowski, MD, also assessed the feasibility of a CSF biomarker for this disease.
Transplantation and radiation are prominent topics in this expert panel segment, moderated by Grzegorz Nowakowski, MD.
The panel, moderated by Grzegorz Nowakowski, MD, discussed options like lenalidomide, BTK inhibitors, and clinical trials.
Grzegorz Nowakowski, MD, asks an expert panel about their approaches and special issues they encounter in first-line care.
An expert panel convened at the "HemOnc Pulse" Live meeting in Chicago explores unanswered questions in DLBCL management.
The panel discussed treatment options for Hodgkin lymphoma, maintenance therapy following autologous transplant, and more.
Grzegorz Nowakowski, MD, recounts his experience serving on the FDA ODAC while reviewing the POLARIX data.
At SOHO 2021, Greg Nowakowski, MD, of Mayo Clinic Rochester, discusses what to expect.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.